NASDAQ:VRXA

Veraxa Biotech (VRXA) Stock Price, News & Analysis

Veraxa Biotech logo
$1.04 +0.01 (+1.17%)
Closing price 03:58 PM Eastern
Extended Trading
$1.04 +0.00 (+0.29%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Veraxa Biotech Stock (NASDAQ:VRXA)

Advanced

Key Stats

Today's Range
$1.03
▼
$1.06
50-Day Range
$0.95
▼
$1.65
52-Week Range
$0.90
▼
$27.36
Volume
104,285 shs
Average Volume
402,972 shs
Market Capitalization
$32.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Veraxa Biotech AG is a biotechnology company developing targeted cancer therapies, with a focus on antibody-drug conjugates and antibody-targeted amanitin conjugates. Its approach uses antibodies to direct potent drug payloads toward cancer cells.

The company’s development programs have included HDP-101, targeting BCMA for multiple myeloma; HDP-102, targeting CD37 for B-cell lymphoma; and HDP-103, targeting PSMA for prostate cancer. These are investigational candidates, not approved medicines.

Based in Germany, Veraxa was previously known as Heidelberg Pharma AG. Its work centers on developing antibody-based treatments for cancer.

AI Generated. May Contain Errors.

Receive VRXA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Veraxa Biotech and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VRXA Stock News Headlines

A Bill Would Reprice America's Gold at Market Value
The US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,000 today, leaving a trillion-dollar gap on the books. A bill now moving through Congress would require the Treasury to reprice America's gold at true market value. Companion legislation would trigger the first full audit of US reserves in over 65 years.tc pixel
See More Headlines

VRXA Stock Analysis - Frequently Asked Questions

Veraxa Biotech's stock was trading at $1.35 on August 31, 2026. Since then, VRXA stock has decreased by 23.3% and is now trading at $1.0360.

Shares of VRXA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
11/20/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:VRXA
CIK
2079109
Web
N/A
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
31,620,000
Free Float
N/A
Market Cap
$32.95 million
Optionable
N/A
Beta
0.21
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NASDAQ:VRXA) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners